Previous preclinical studies have shown that ADT upregulates the expression of PSMA in both androgen-sensitive and androgen-resistant human prostate adenocarcinoma cells (LNCaP) [6,14,15]. The gene discussed is FOLH1; the disease is prostate adenocarcinoma.